Cc1ccc(C(C(=O)NC(C)(C)C)N(Cc2ccco2)C(=O)Cn2nnc(-c3cccs3)n2)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?